Tumor Regression by Targeted Gene Delivery to the Neovasculature

See allHide authors and affiliations

Science  28 Jun 2002:
Vol. 296, Issue 5577, pp. 2404-2407
DOI: 10.1126/science.1070200

You are currently viewing the abstract.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

This article has a correction. Please see:


Efforts to influence the biology of blood vessels by gene delivery have been hampered by a lack of targeting vectors specific for endothelial cells in diseased tissues. Here we show that a cationic nanoparticle (NP) coupled to an integrin αvβ3–targeting ligand can deliver genes selectively to angiogenic blood vessels in tumor-bearing mice. The therapeutic efficacy of this approach was tested by generating NPs conjugated to a mutant Raf gene,ATPμ-Raf, which blocks endothelial signaling and angiogenesis in response to multiple growth factors. Systemic injection of the NP into mice resulted in apoptosis of the tumor-associated endothelium, ultimately leading to tumor cell apoptosis and sustained regression of established primary and metastatic tumors.

  • * To whom correspondence should be addressed. E-mail: cheresh{at}

View Full Text

Stay Connected to Science